Providing for pharmaceutical transparency; establishing the Pharmaceutical Transparency Review Board and providing for its powers and duties; establishing the Pharmaceutical Transparency Review Fund; and imposing a penalty.
To promote transparency in prescription drug prices
To ensure prescription drug cost transparency and affordability
Further providing for title of act; in preliminary provisions, further providing for short title, for scope of act and for definitions and providing for regulations; in pharmacy audits, further providing for limitations; in registration, further providing for PBM and auditing entity registration; providing for pharmacy benefits manager contracts; in PBM cost transparency requirements, providing for PBM transparency report required, repealing provisions relating to regulations and providing for PSAO reporting requirements; in enforcements, further providing for scope of enforcement authority; providing for pharmacy services; and making repeals.
Relative to pharmaceutical access, costs and transparency
A bill for an act relating to prescription drug affordability, including the creation of a prescription drug affordability board.
A bill for an act relating to prescription drug affordability, including the creation of a prescription drug affordability board.
To promote transparency and prevent price gouging of pharmaceutical drug prices